39- Physician-Entrepreneur Series: Khizer Khaderi (Vizzario)

Episode 39 April 05, 2023 01:01:21
39- Physician-Entrepreneur Series: Khizer Khaderi (Vizzario)
Physicians Off The Beaten Path
39- Physician-Entrepreneur Series: Khizer Khaderi (Vizzario)

Apr 05 2023 | 01:01:21


Hosted By

Alexey Youssef Shad Faraz

Show Notes

Why is the cross-pollination of ideas so important in healthcare? How and when to jump into entrepreneurship? What is perceptual AI? How to use video games for good? How to promote wellness through esports? In this episode, we answer all these questions and more with Dr. Khizer Khaderi, MD, MPH.

Khizer is a Neuro-Ophthalmic surgeon. He is a Clinical Associate Professor at the Byers Eye Institute at Stanford University, the Director/Founder of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC), and faculty at the Stanford Institute for Human-Centered AI. Khizer is an advisor to Magic Leap, NBA, Aerie Pharma, the Global Esports Federation, CompHealth Global, and the World Health Organization. He is the Founder of Vizzario, a perceptual AI company. He graduated from the University of Utah in 2002 and did a residency in ophthalmology at the University of Arizona.

If you've found our podcast helpful, buy us a coffee

Other Episodes

Episode 19

March 09, 2022 00:42:03
Episode Cover

19- Physician-Investor Series: Justin Norden, MD (GSR Ventures)

Why is there a mismatch between VC companies and some vulnerable patient populations? Do we need a radical transformation from the ground up of...


Episode 9

September 08, 2021 00:42:19
Episode Cover

06- Physician-Writer Series: David Fajgenbaum, MD (Castleman Disease Collaborative Network)

What is it like to navigate the healthcare system both as a healthcare professional and as a patient? What is the state of research...


Episode 41

April 28, 2023 00:48:03
Episode Cover

41- Physician-Investor Series: Andrey Ostrovsky (Social Innovation Ventures & US Medicaid Program)

What are some of the inflection points that are needed to unlock the commercial side of the market of digital therapeutics? How can MDs...